Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
BVS	BIOVENTUS INC	$745.90M	13.80%	3.30%	9.11%	11.20%	2.47	1.70	68.30%	4.00%	8.39%
AMRX	AMNEAL PHARMACEUTICALS INC	$3.93B	-68.00%	2.00%	11.60%	8.60%	-52.97	2.17	36.90%	2.40%	10.75%
AVAH	AVEANNA HEALTHCARE HOLDINGS INC	$1.39B	983.50%	12.40%	15.56%	15.60%	9.35	1.32	33.30%	9.20%	10.15%
INFU	INFUSYSTEM HOLDINGS INC	$187.80M	11.90%	6.60%	14.83%	12.00%	0.75	1.80	56.00%	4.60%	8.31%
VMD	VIEMED HEALTHCARE INC	$371.74M	10.90%	7.80%	14.24%	21.50%	0.39	1.18	57.50%	5.50%	8.33%
INDV	INDIVIOR PHARMACEUTICALS INC	$3.81B	-99.20%	15.40%	98.95%	80.70%	-13.27	0.71	80.10%	16.90%	22.92%
TCMD	TACTILE SYSTEMS TECHNOLOGY INC	$552.00M	9.30%	7.00%	13.90%	28.90%	0.25	4.03	75.90%	5.80%	9.83%
JAZZ	JAZZ PHARMACEUTICALS PLC	$11.51B	-8.80%	-3.10%	-4.60%	-6.20%	1.70	1.86	88.20%	-8.30%	-10.16%
PHAR	PHARMING GROUP NV	$1.17B	1.10%	0.60%	3.43%	5.40%	0.80	2.59	87.90%	0.80%	3.50%
INVA	INNOVIVA INC	$1.70B	30.60%	19.20%	21.67%	35.20%	0.39	14.64	74.80%	65.90%	83.52%
AUPH	AURINIA PHARMACEUTICALS INC	$2.08B	70.40%	50.20%	18.01%	23.80%	0.29	5.25	88.50%	101.50%	41.86%
ELMD	ELECTROMED INC	$192.73M	20.30%	16.70%	26.33%	40.80%	0.21	4.86	78.20%	13.10%	17.41%
EMBC	EMBECTA CORP	$524.10M	-20.90%	12.60%	36.12%	14.40%	-2.74	2.64	63.10%	12.90%	27.73%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$34.59B	20.00%	3.50%	7.93%	9.50%	4.15	1.04	51.80%	8.20%	12.54%
PAHC	PHIBRO ANIMAL HEALTH CORP	$2.25B	30.80%	6.70%	14.96%	10.10%	3.23	3.05	31.90%	6.30%	11.47%
INNV	INNOVAGE HOLDING CORP	$1.03B	2.70%	1.20%	3.34%	5.30%	0.93	1.26	20.30%	0.70%	1.40%
OPRX	OPTIMIZERX CORP	$123.08M	4.20%	3.00%	7.87%	25.70%	0.38	3.04	67.30%	4.70%	11.19%
VCYT	VERACYTE INC	$2.56B	5.30%	4.90%	5.07%	34.00%	0.07	8.15	70.10%	12.80%	13.19%
BMY	BRISTOL MYERS SQUIBB CO	$121.37B	39.30%	7.50%	14.00%	15.30%	3.87	1.26	71.10%	14.60%	19.35%
BCRX	BIOCRYST PHARMACEUTICALS INC	$2.26B	-76.50%	55.60%	108.86%	39.00%	-5.32	2.06	97.80%	30.20%	39.58%
ILMN	ILLUMINA INC	$19.48B	34.90%	13.60%	23.46%	25.30%	1.44	2.08	66.10%	19.60%	27.33%
ASMB	ASSEMBLY BIOSCIENCES INC	$460.18M	-5.60%	-3.60%	-2.93%	-6.70%	0.25	5.22	N/A	N/A	N/A
AUNA	AUNA SA	$418.67M	N/A	N/A	N/A	N/A	N/A	N/A	37.90%	2.20%	19.09%
PBYI	PUMA BIOTECHNOLOGY INC	$351.05M	27.80%	15.40%	31.40%	62.00%	0.66	2.00	74.50%	13.60%	18.57%
VREX	VAREX IMAGING CORP	$439.95M	-13.90%	-5.80%	-2.56%	-2.40%	1.27	3.89	34.20%	-7.90%	-2.80%
ALGN	ALIGN TECHNOLOGY INC	$12.16B	10.40%	6.60%	13.57%	21.20%	0.54	1.36	67.20%	10.20%	14.51%
LIVN	LIVANOVA PLC	$3.49B	-21.50%	-9.50%	-9.54%	-28.90%	1.17	1.36	67.70%	-17.50%	-12.36%
TBRG	TRUBRIDGE INC	$242.09M	2.50%	1.10%	4.70%	7.80%	1.26	1.81	53.00%	1.30%	4.67%
MD	PEDIATRIX MEDICAL GROUP INC	$1.76B	19.60%	7.70%	14.12%	28.30%	1.60	1.66	25.80%	8.60%	13.19%
THC	TENET HEALTHCARE CORP	$16.36B	34.80%	4.80%	10.55%	11.70%	4.91	1.76	100.00%	6.60%	12.49%
SNN	SMITH & NEPHEW PLC	$14.11B	11.80%	6.00%	10.37%	12.20%	0.98	2.57	68.00%	10.10%	14.91%
GILD	GILEAD SCIENCES INC	$173.44B	41.00%	14.80%	22.92%	29.30%	1.60	1.55	78.80%	28.90%	36.75%
LNTH	LANTHEUS HOLDINGS INC	$4.92B	20.60%	10.80%	17.61%	28.60%	1.04	2.70	61.10%	15.20%	21.64%
NVST	ENVISTA HOLDINGS CORP	$4.23B	1.50%	0.80%	4.43%	9.60%	0.83	2.38	54.70%	1.70%	7.86%
SPRO	SPERO THERAPEUTICS INC	$140.68M	22.50%	13.00%	14.71%	85.80%	0.17	7.59	100.00%	12.80%	13.22%
CCLD	CARECLOUD INC	$142.35M	6.80%	4.80%	17.86%	66.40%	0.47	1.05	46.50%	3.20%	9.36%
ABBV	ABBVIE INC	$369.26B	-361.60%	3.10%	10.17%	13.60%	-41.95	0.67	70.20%	6.90%	15.07%
EXEL	EXELIXIS INC	$11.40B	36.90%	28.00%	38.59%	42.20%	0.32	3.56	96.40%	33.70%	40.57%
ATRC	ATRICURE INC	$1.45B	-2.40%	-1.80%	-0.75%	-2.10%	0.33	3.96	75.00%	-2.10%	-0.80%
GRDN	GUARDIAN PHARMACY SERVICES INC	$2.41B	27.50%	13.20%	29.51%	58.80%	0.95	1.38	20.20%	3.40%	5.13%
GMED	GLOBUS MEDICAL INC	$11.89B	12.40%	10.70%	12.45%	28.70%	0.16	4.26	67.40%	18.30%	20.35%
ANIK	ANIKA THERAPEUTICS INC	$198.33M	-7.40%	-5.70%	-6.06%	-7.90%	0.33	4.72	56.60%	-9.60%	-9.05%
XERS	XERIS BIOPHARMA HOLDINGS INC	$1.04B	-5.30%	0.20%	10.82%	9.50%	27.02	2.19	85.40%	0.20%	10.16%
SHC	SOTERA HEALTH CO	$4.25B	15.00%	2.40%	10.06%	8.50%	4.38	2.46	55.50%	6.70%	26.06%
ELAN	ELANCO ANIMAL HEALTH INC	$11.47B	-3.50%	-1.70%	-0.03%	-0.10%	1.04	2.17	55.00%	-4.90%	-0.08%
CAH	CARDINAL HEALTH INC	$50.37B	-57.80%	3.10%	17.46%	37.40%	-21.08	0.91	3.70%	0.70%	1.05%
CNMD	CONMED CORP	$1.07B	4.70%	2.00%	5.08%	7.10%	1.25	2.14	54.60%	3.40%	7.43%
TAK	TAKEDA PHARMACEUTICAL CO LTD	$59.20B	1.60%	0.80%	4.45%	7.00%	1.02	1.19	65.30%	2.50%	12.75%
VRTX	VERTEX PHARMACEUTICALS INC	$111.45B	22.70%	16.20%	21.38%	29.90%	0.37	2.90	86.20%	32.90%	38.80%
FMS	FRESENIUS MEDICAL CARE AG	$12.52B	7.30%	3.10%	6.80%	7.70%	1.26	1.27	25.60%	5.00%	8.58%
MMSI	MERIT MEDICAL SYSTEMS INC	$4.02B	8.50%	5.00%	8.07%	10.70%	0.70	4.34	48.70%	8.50%	13.02%
IRMD	IRADIMED CORP	$1.23B	23.80%	20.80%	28.76%	67.90%	0.15	7.98	76.70%	26.80%	33.84%
TBPH	THERAVANCE BIOPHARMA INC	$824.92M	46.00%	25.40%	29.45%	55.30%	0.64	10.93	100.00%	98.50%	122.56%
SUPN	SUPERNUS PHARMACEUTICALS INC	$2.91B	-3.70%	-2.80%	-4.40%	-15.30%	0.37	1.91	89.60%	-5.40%	-6.82%
LLY	ELI LILLY & CO	$882.59B	97.90%	19.80%	33.31%	28.20%	3.24	1.58	83.00%	31.70%	39.48%
MDXG	MIMEDX GROUP INC	$582.38M	21.20%	15.90%	22.75%	60.00%	0.34	4.32	82.60%	11.60%	15.13%
BTSG	BRIGHTSPRING HEALTH SERVICES INC	$8.34B	10.70%	3.10%	8.35%	9.20%	2.41	1.57	11.80%	1.50%	2.95%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$2.93B	-10.30%	-4.30%	-0.95%	-0.90%	1.29	3.17	90.20%	-4.30%	-0.77%
NHC	NATIONAL HEALTHCARE CORP	$2.53B	11.60%	7.70%	13.06%	14.80%	0.42	1.82	100.00%	7.90%	10.95%
VTRS	VIATRIS INC	$15.47B	-23.00%	-9.20%	-10.61%	-14.50%	1.53	1.38	35.10%	-24.60%	-22.33%
BWAY	BRAINSWAY LTD	$512.81M	11.10%	7.00%	10.93%	42.30%	0.54	3.83	75.40%	14.60%	18.99%
NBIX	NEUROCRINE BIOSCIENCES INC	$13.21B	16.70%	11.60%	18.14%	20.00%	0.42	3.39	98.20%	16.70%	24.66%
RPRX	ROYALTY PHARMA PLC	$28.02B	8.00%	4.10%	5.68%	4.40%	1.02	2.40	100.00%	32.40%	45.35%
KMDA	KAMADA LTD	$488.60M	7.70%	5.40%	7.34%	18.10%	0.41	4.07	42.30%	11.20%	13.48%
BLLN	BILLIONTOONE INC	$3.65B	2.60%	0.60%	1.34%	4.00%	0.32	11.69	68.30%	1.00%	2.57%
KRMD	KORU MEDICAL SYSTEMS INC	$200.32M	-15.90%	-9.80%	-13.08%	-18.80%	0.65	2.44	62.30%	-6.40%	-6.36%
CON	CONCENTRA GROUP HOLDINGS PARENT INC	$2.69B	46.60%	5.90%	12.96%	11.50%	6.20	1.14	28.30%	7.70%	15.10%
AGEN	AGENUS INC	$127.87M	N/A	0.00%	-57.28%	-318.60%	-1.86	0.41	99.10%	-0.10%	48.50%
AXGN	AXOGEN INC	$1.79B	-13.40%	-7.50%	-4.04%	-3.60%	0.72	5.11	74.30%	-7.00%	-3.55%
GRFS	GRIFOLS SA	$5.67B	2.70%	0.70%	5.73%	5.80%	2.18	2.66	38.70%	2.20%	15.29%
IRWD	IRONWOOD PHARMACEUTICALS INC	$577.23M	-8.20%	6.60%	66.44%	16.30%	-2.52	1.13	100.00%	8.10%	34.70%
GSK	GSK PLC	$115.52B	37.20%	9.40%	18.95%	24.70%	2.76	0.82	72.40%	17.50%	23.05%
ADUS	ADDUS HOMECARE CORP	$1.70B	9.20%	6.80%	10.95%	47.10%	0.32	1.80	32.50%	6.70%	9.92%
COO	COOPER COMPANIES INC	$13.69B	4.80%	3.20%	6.48%	8.60%	0.49	1.34	65.40%	9.70%	16.90%
DVA	DAVITA INC	$9.72B	-160.60%	4.30%	11.30%	8.70%	-25.07	1.29	32.20%	5.50%	11.87%
LMAT	LEMAITRE VASCULAR INC	$2.47B	15.60%	9.80%	13.87%	13.10%	0.57	12.89	71.50%	23.10%	32.20%
HSIC	HENRY SCHEIN INC	$8.48B	11.90%	3.60%	8.44%	11.30%	1.98	1.38	31.10%	3.00%	5.11%
IDXX	IDEXX LABORATORIES INC	$45.35B	69.80%	31.90%	61.90%	54.50%	1.09	1.23	61.80%	24.60%	31.67%
LFST	LIFESTANCE HEALTH GROUP INC	$2.46B	0.70%	0.40%	1.23%	3.40%	0.45	1.65	32.40%	0.70%	1.69%
GLPG	GALAPAGOS NV	$1.94B	11.60%	8.70%	9.29%	9.60%	0.05	20.15	97.30%	28.90%	27.18%
HAE	HAEMONETICS CORP	$2.64B	20.30%	7.10%	12.87%	14.10%	1.73	1.75	59.40%	13.30%	19.05%
PACS	PACS GROUP INC	$5.05B	N/A	N/A	6.83%	N/A	4.89	1.07	14.80%	3.60%	5.92%
CGEN	COMPUGEN LTD	$213.69M	55.70%	29.70%	26.42%	197.10%	0.52	6.56	87.30%	48.60%	48.65%
ZTS	ZOETIS INC	$49.79B	58.20%	18.10%	27.07%	25.70%	3.64	3.03	71.80%	28.20%	37.84%
SYK	STRYKER CORP	$126.88B	15.00%	6.90%	12.79%	18.60%	1.13	1.89	64.00%	12.90%	20.39%
TMO	THERMO FISHER SCIENTIFIC INC	$182.57B	13.10%	6.50%	9.11%	15.30%	1.07	1.89	40.90%	15.00%	19.46%
MTD	METTLER TOLEDO INTERNATIONAL INC	$25.61B	-487.20%	25.10%	44.44%	32.60%	-158.08	1.14	59.40%	21.60%	27.75%
STE	STERIS PLC	$21.45B	10.20%	6.80%	10.33%	18.90%	0.48	2.48	44.10%	12.10%	17.14%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$47.41M	-10.50%	-4.00%	-5.74%	-9.90%	2.10	1.01	85.00%	-6.40%	-5.17%
HCA	HCA HEALTHCARE INC	$105.51B	-140.80%	11.30%	24.98%	13.90%	-10.53	0.97	41.50%	9.00%	14.66%
NEOG	NEOGEN CORP	$2.05B	-26.90%	-17.00%	-17.16%	-36.80%	0.60	3.91	46.00%	-68.50%	-62.63%
ORGO	ORGANOGENESIS HOLDINGS INC	$288.16M	7.80%	3.90%	8.96%	12.60%	0.55	3.62	75.60%	3.50%	7.92%
ESPR	ESPERION THERAPEUTICS INC	$670.28M	N/A	-6.00%	38.63%	11.90%	-2.54	1.54	67.90%	-5.60%	15.82%
MRK	MERCK & CO INC	$298.84B	36.20%	14.60%	20.65%	26.10%	1.60	1.54	74.80%	28.10%	34.48%
WST	WEST PHARMACEUTICAL SERVICES INC	$18.35B	16.70%	12.40%	17.03%	20.60%	0.34	3.02	35.90%	16.10%	20.03%
OMDA	OMADA HEALTH INC	$741.28M	-18.80%	-4.90%	-4.46%	-54.30%	0.33	3.60	65.70%	-4.90%	-3.94%
ANIP	ANI PHARMACEUTICALS INC	$1.66B	16.20%	5.60%	9.97%	12.30%	1.66	2.71	61.40%	8.70%	13.11%
SLGL	SOL-GEL TECHNOLOGIES LTD	$221.39M	-23.70%	-18.60%	-25.80%	-47.00%	0.31	4.37	100.00%	-31.60%	-31.60%
PCRX	PACIRA BIOSCIENCES INC	$976.58M	0.90%	0.50%	3.00%	3.10%	0.83	4.54	79.40%	1.00%	4.72%
BHC	BAUSCH HEALTH COMPANIES INC	$1.98B	-20.50%	0.60%	9.05%	7.80%	-46.91	1.47	70.70%	1.50%	19.56%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	606	-0.01%	+3.43%	-0.16%	-29.10%	28.69x	4.77x	-38.36%	-14.24%	-8.58%	+63.52%	Strong Buy
Diagnostics & Research	55	+0.31%	+1.69%	-3.45%	+10.47%	20.41x	3.69x	-2.71%	+6.61%	+12.95%	+25.93%	Strong Buy
Drug Manufacturers - General	20	-1.34%	+2.11%	-6.55%	+20.55%	32.72x	7.01x	+10.22%	+12.41%	+21.10%	+19.20%	Buy
Drug Manufacturers - Specialty & Generic	75	-1.19%	+0.83%	-6.28%	-27.18%	-196.18x	1.63x	+9.19%	+2.51%	+7.27%	+43.81%	Strong Buy
Healthcare Plans	10	+1.24%	+1.76%	-5.45%	-36.04%	22.78x	1.80x	+9.09%	+2.85%	+6.97%	+25.73%	Buy
Health Information Services	55	+0.55%	-0.27%	-8.49%	-80.30%	23.49x	2.80x	-7.72%	+2.33%	+4.64%	+61.04%	Buy
Medical Care Facilities	50	-0.22%	-1.38%	-10.26%	-42.38%	18.03x	5.29x	-68.62%	+7.35%	+19.11%	+25.02%	Buy
Medical Devices	137	-0.07%	-1.18%	-9.86%	-66.48%	23.94x	3.27x	+8.46%	+5.25%	+9.40%	+54.60%	Strong Buy
Medical Distribution	10	+1.45%	+2.26%	-10.46%	+25.96%	29.76x	317.88x	-99.39%	+3.30%	+23.34%	+14.03%	Strong Buy
Medical Instruments & Supplies	57	-0.61%	+0.07%	-7.92%	-10.20%	-490.95x	3.36x	+9.37%	+7.41%	+4.05%	+32.85%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Apr 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 17 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock lose -5.68% over the past year, overperforming other healthcare stocks by 30 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 67.22% from Bioventus's current stock price of $8.97.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: C, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 35, which is 8 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 52.75% over the past year, overperforming other healthcare stocks by 88 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $15.00, an upside of 20.19% from Amneal Pharmaceuticals's current stock price of $12.48.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

Aveanna Healthcare Holdings (NASDAQ:AVAH) is the #3 top healthcare stock out of 1075 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aveanna Healthcare Holdings (NASDAQ:AVAH) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Aveanna Healthcare Holdings (NASDAQ:AVAH) has a Due Diligence Score of 32, which is 5 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Aveanna Healthcare Holdings has seen its stock return 13.52% over the past year, overperforming other healthcare stocks by 49 percentage points.

Aveanna Healthcare Holdings has an average 1 year price target of $10.00, an upside of 56.74% from Aveanna Healthcare Holdings's current stock price of $6.38.

Aveanna Healthcare Holdings stock has a consensus Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Aveanna Healthcare Holdings, 33.33% have issued a Strong Buy rating, 16.67% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

Novabay Pharmaceuticals (NYSEMKT:NBY) has an annual dividend yield of 205.13%, which is 200 percentage points higher than the healthcare sector average of 4.92%.

Novabay Pharmaceuticals's dividend payout ratio of -105.3% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 24.18%, which is 19 percentage points higher than the healthcare sector average of 4.92%.

Dominari Holdings's dividend payout ratio of -42.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.23%, which is 6 percentage points higher than the healthcare sector average of 4.92%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 162.3% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.05% in the last day, and up 1.62% over the last week. Lipocine was the among the top losers in the healthcare sector, dropping -77.84% yesterday.

Lipocine shares are trading lower after the company's LPCN 1154 missed its Phase 3 primary endpoint in postpartum depression.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 70 points higher than the healthcare sector average of 16. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -29.31% in the past year. It has overperformed other stocks in the healthcare sector by 6 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 145.83% in the past year. It has overperformed other stocks in the healthcare sector by 181 percentage points.

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -14.72% in the past year. It has overperformed other stocks in the healthcare sector by 21 percentage points.

Are healthcare stocks a good buy now?

58.29% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 44.05% over the next year.

5.73% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.7% of healthcare stocks are rated B (Buy), 50.93% are rated C (Hold), 23.91% are rated D (Sell), and 6.72% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is -8.01x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aveanna Healthcare Holdings (NASDAQ:AVAH)

1. Novabay Pharmaceuticals (NYSEMKT:NBY)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Harmony Biosciences Holdings (NASDAQ:HRMY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.